Relay Therapeutics (RLAY) Stock
Relay Therapeutics (RLAY) closed at $18.09 on Nov 13, 2026; its Tenet Score is 43 of 100 against 313 Healthcare peers.
34 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $18.09
- Nov 13, 2026
- Market cap
- $4.0B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 6.04 – 21.27
- low → high · as of close, Nov 13, 2026
- Tenet Score
- 43/100
- Weak · 313 Healthcare peers
Industry: Drugs
Relay Therapeutics Inc scores 43/100. Weak. Strongest on financial health, growth is the soft spot versus 313 Healthcare peers.
Tenet Score · vs sector
n=313Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✓ Drawdown Context
- ~ Reversal Evidence
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indicat…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Definium Therapeutics Inc.DFTX | 49 | $4.4B |
| CRISPR Therapeutics AGCRSP | 64 | $4.1B |
| Xenon Pharmaceuticals IncXENE | 44 | $4.0B |
| Tarsus Pharmaceuticals IncTARS | 33 | $4.0B |
| Amylyx Pharmaceuticals IncAMLX | 55 | $3.9B |
| Viking Therapeutics IncVKTX | 36 | $3.7B |
| Organon & Co.OGN | 45 | $3.7B |
| Enliven Therapeutics IncELVN | 59 | $3.6B |
| Iovance Biotherapeutics IncIOVA | 52 | $3.6B |
| Arcutis Biotherapeutics IncARQT | 43 | $3.6B |
Common questions
What sector and industry is Relay Therapeutics in?
Relay Therapeutics is in the Healthcare sector and the Drugs industry.
What is Relay Therapeutics' Tenet Score?
Relay Therapeutics' Tenet Score is 43 out of 100, ranked against 313 Healthcare peers as of Nov 13, 2026.




